CSL reported $18M in Interest Income for its fiscal semester ending in December of 2024.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
aTyr Pharma USD 6.53K 1.31K Mar/2026
Bio Path USD 4K 0 Dec/2024
Cara Therapeutics USD 347K 74K Mar/2025
CSL USD 18M 1000K Dec/2024
Curis USD 806K 9K Sep/2023
Immunic USD -0.24 0.03 Sep/2024